Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Influenza

  Free Subscription


12.08.2019

2 J Virol
1 PLoS Comput Biol
1 PLoS One
1 Proc Natl Acad Sci U S A
3 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    J Virol

  1. DHAKAL S, Klein SL
    Host factors impact vaccine efficacy: implications for seasonal and universal influenza vaccine programs.
    J Virol. 2019 Aug 7. pii: JVI.00797-19. doi: 10.1128/JVI.00797.
    PubMed     Text format     Abstract available

  2. LIMBURG H, Harbig A, Bestle D, Stein DA, et al
    TMPRSS2 is the major activating protease of influenza A virus in primary human airway cells and influenza B virus in human type II pneumocytes.
    J Virol. 2019 Aug 7. pii: JVI.00649-19. doi: 10.1128/JVI.00649.
    PubMed     Text format     Abstract available


    PLoS Comput Biol

  3. YANG J, Muller NF, Bouckaert R, Xu B, et al
    Bayesian phylodynamics of avian influenza A virus H9N2 in Asia with time-dependent predictors of migration.
    PLoS Comput Biol. 2019;15:e1007189.
    PubMed     Text format     Abstract available


    PLoS One

  4. PALEKAR R, Rodriguez A, Avila C, Barrera G, et al
    Patterns of influenza B circulation in Latin America and the Caribbean, 2010-2017.
    PLoS One. 2019;14:e0219595.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  5. SCHMIDT N, Domingues P, Golebiowski F, Patzina C, et al
    An influenza virus-triggered SUMO switch orchestrates co-opted endogenous retroviruses to stimulate host antiviral immunity.
    Proc Natl Acad Sci U S A. 2019 Aug 7. pii: 1907031116.
    PubMed     Text format     Abstract available


    Vaccine

  6. STARK FC, Akache B, Ponce A, Dudani R, et al
    Archaeal glycolipid adjuvanted vaccines induce strong influenza-specific immune responses through direct immunization in young and aged mice or through passive maternal immunization.
    Vaccine. 2019 Aug 2. pii: S0264-410X(19)30888.
    PubMed     Text format     Abstract available

  7. TZENG TT, Lai CC, Weng TC, Cyue MH, et al
    The stability and immunogenicity of inactivated MDCK cell-derived influenza H7N9 viruses.
    Vaccine. 2019 Aug 2. pii: S0264-410X(19)30346.
    PubMed     Text format     Abstract available

  8. NOH JY, Jang YS, Lee SN, Choi MJ, et al
    Randomized, single-blind, active-controlled phase I clinical trial to evaluate the immunogenicity and safety of GC3114 (high-dose, quadrivalent influenza vaccine) in healthy adults.
    Vaccine. 2019 Jul 31. pii: S0264-410X(19)30997.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: